Lasa Supergenerics Limited announced the appointment of Ankita Shetty as Company Secretary and Compliance Officer, effective November 15, 2021. She succeeds Nidhi Kulshreshtha, who resigned from the role w.e.f November 14, 2021. According to the company’s exchange filing, “The Board of Directors at its meeting held on November 15, 2021 has appointed Ms. Ankita Shetty,…
API major, Lasa Supergenerics Ltd in collaboration with Institute of Chemical Technology (ICT) recently announced commencement for Development of antiviral Compound Favipiravir as Covid-19 Treatment. Commenting on the development, Dr Omkar Herlekar, Chairman– Lasa Supergenerics Limited, said Health and safety of our countrymen is of pristine importance and to safeguard them from deadly corona we…